Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials.
about
Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?Ubiquitin Specific Protease 26 (USP26) expression analysis in human testicular and extragonadal tissues indicates diverse action of USP26 in cell differentiation and tumorigenesis.Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomesIntermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis.Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details.Unrecognized kinetics of serum testosterone: impact on short-term androgen deprivation therapy for prostate cancer.Intermittent androgen deprivation therapy in advanced prostate cancer.Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients.The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.First off-time treatment prostate-specific antigen kinetics predicts survival in intermittent androgen deprivation for prostate cancer.Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.Clinical characteristics and quality-of-life in patients surviving a decade of prostate cancer with bone metastases.Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII.International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.Androgen deprivation and immunotherapy for the treatment of prostate cancerRe: A review of continuous vs intermittent androgen deprivation therapy: redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ″perpetual dispute″
P2860
Q28385758-39C4CFAD-E4AE-4036-A97E-E9B82674F4F1Q33747869-3C9FB0BE-8B91-45B1-A30E-31E572CBB22EQ33890406-10C31313-1532-4D6B-96A8-EA532B2103ACQ37554029-0AAD9DB3-A25F-48CE-8E5D-23D0FD9B5B8BQ37592301-4A573D00-3FBF-49C3-952A-5932798E21B2Q37708192-3251A024-B623-4A56-9347-50F3E0CACE6BQ38176254-7201F872-0F7E-46E6-B598-7818018DD3C2Q38179060-9E621BFE-8885-434A-9220-F611A74B2DC3Q38537545-6CD523EE-F84B-40C8-BB56-892300FD5942Q38946665-D0B485DA-636E-4B21-B25A-916B6C956A81Q39406932-8BBCEC4B-0E61-452C-AA29-11DF3B6E9122Q41188480-4F25EDC4-1D11-4AE6-8654-BB8FFF6FACC7Q41839868-4DA8F197-0DFD-495C-8E8F-12EBAA48D512Q48037073-A7C6C371-3159-4F3B-99F6-9A2B25979366Q48081685-143DCE02-F730-4F27-9D9E-6D0A84664449Q54917990-E1C19666-706E-4EC8-978E-8378B1EB032AQ54940363-E25EC584-CAEA-461E-8971-E58A2B7652FFQ57115565-B93850B4-D908-44CF-9D30-D9AA8B67B10EQ57128917-0E0BECAE-BB0B-414E-9831-D41D3D7F7759
P2860
Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@ast
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@en
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@nl
type
label
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@ast
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@en
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@nl
prefLabel
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@ast
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@en
Intermittent androgen-deprivat ...... iew focused on phase 3 trials.
@nl
P2093
P1433
P1476
Intermittent androgen-deprivat ...... view focused on phase 3 trials
@en
P2093
Fernando Calais da Silva
Matthew Galsky
Maurizio Brausi
Nicolas Mottet
Oliver Sartor
Per Anders Abrahamsson
Teuvo L J Tammela
P304
P356
10.1016/J.EURURO.2013.04.020
P407
P577
2013-04-19T00:00:00Z